Patient basic information Patient: Mr. John (John King) Nationality: Australia Disease diagnosis: Leukemia Diagnostic Hospital: H1N1 Treatment: Immunotherapy + Targeted Treatment Accommodation: 136 days Treatment cost: approximately 441204 yuan Treatment effect: Healing The patient is from Australia and was diagnosed with Leukemia locally. Following the arrival of the patient, for the first time, the International Medical Service Team arranged multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on the patient's examination reports and physical condition, and provided translation, accompaniment and on-site services throughout the treatment process.
The Therapy Team employs a comprehensive set of immunotherapy + targeted therapies, during which the medical team closely monitors the patient's indicators, dynamic adjustment programs. After 136 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching outpatient standards. Treatment results The patient finally recovered.
When he left the hospital, the medical team developed a detailed return follow-up and rehabilitation plan for him, and continued to track recovery through a remote follow-up system. 'Mr. John has criticized the case as a typical case of cross-border suspected seriousness clinical illness.
The multi-disciplinary collaborative mechanism for developing immunotherapy + targeted treatments for leukemia reflects the comprehensive strength of Chinese hospitals in the field of suspected illness clinics and is a shorthand for the regulation of international visitor medical services.